Spinocerebellar Ataxia Type 15/16

Neurology·MeSH: Coffin-Lowry Syndrome

Prevalence

0.1 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Spinocerebellar Ataxia Type 15/16?

There are 1 clinical trial targeting Spinocerebellar Ataxia Type 15/16 tracked by BioSniper.

What is the prevalence of Spinocerebellar Ataxia Type 15/16?

The estimated prevalence of Spinocerebellar Ataxia Type 15/16 is approximately 0.1 per 100,000 population.

Deep-dive into Spinocerebellar Ataxia Type 15/16

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Spinocerebellar Ataxia Type 15/16 — Drugs in Development & Clinical Trials | BioSniper